pembrolizumab,mrna-4157
merck,moderna
['key,note,42', 'keynote,942', 'melanoma', 'pembro']
phase 2 keynote 942 presented show benefit in rfs in stage iii-iv resected melanoma when personalized mrna vaccine was added to pembrolizumab!!! 16% relapse free benefit at 18-months complicates treatments for resectable melanoma neoadjuvant mrna next? #aacr23 #melanoma 
Incoming @ The Angeles Clinic and Research Institute Cedars Sinai affiliate with phase 1 interesr. Frmr phase 1 fellow at MD Anderson & faculty UCI. KU Alum.